about
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...
Read More
4.18
0.09
(2.20%)
5,896.4
XNAS Volume
XNAS 06 Oct, 2026 11:35 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Passage Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..